2

This review on CEST MRI presented recent developments in both clinical and preclinical studies for Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and Huntington’s disease. The findings suggest that chemical exchange saturation transfer magnetic resonance imaging has the potential to detect molecular changes and altered metabolism, which may aid in early diagnosis and assessment of the severity of neurodegenerative diseases.